Skip to content
WeighLab

Mint Med vs Embody

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Mint Med

Provider comparison

Patients in its listed states who want a published monthly all-dose price and are comfortable canceling at least 48 business hours before processing.

Semaglutide / month
$89/moAll doses, month-to-month, compounded
Tirzepatide / month
$119/moAll doses, month-to-month, compounded
Index 81/100 · Grade B−Checked October 2026

Embody

Affiliate partner

Shoppers who want a low monthly price on a compounded GLP-1 with no long-term contract, and who will check the renewal price before each refill.

Semaglutide / month
$79/moSale price, compounded
Tirzepatide / month
$129/moSale price, compounded
Index 77/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Mint Med has the higher Cost-Efficiency Index: 81/100 versus 77/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Mint Med
36 states (published list; confirm yours)
Embody
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Mint Med

Embody

Semaglutide / month
Mint Med: $89/moAll doses, month-to-month, compounded
Embody: $79/moSale price, compounded
Tirzepatide / month
Mint Med: $119/moAll doses, month-to-month, compounded
Embody: $129/moSale price, compounded
Semaglutide / year (modeled)
Mint Med: $1,068
Embody: $948
Tirzepatide / year (modeled)
Mint Med: $1,428
Embody: $1,548
State availability
Mint Med: 36 states (published list; confirm yours)
Embody: All 50 states
Oral / sublingual option listed
Mint Med: Not listed
Embody: Yes
Brand-name access listed
Mint Med: Not confirmed
Embody: Not confirmed
Provider facts checked
Mint Med: October 2026
Embody: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Mint Med

Patients in its listed states who want a published monthly all-dose price and are comfortable canceling at least 48 business hours before processing.

Reasons to consider it

  • Publishes distinct monthly prices for each molecule, with all doses included
  • Names founder Dr. Roderick Huff, MD
  • No separate membership fee

What to weigh up

  • Payment comes before clinical approval; ineligible applicants are refunded
  • Cancellation must use the official form at least 48 business hours before the next order processes
  • Processed prescriptions are non-refundable

Regulatory note: the FDA issued a warning letter to Glow Medispa, LLC dba Mint Med in June 2026. We still list and link to Mint Med; you should know the letter is on the public record before you decide.

Embody

Shoppers who want a low monthly price on a compounded GLP-1 with no long-term contract, and who will check the renewal price before each refill.

Reasons to consider it

  • Semaglutide is $79 for one month, $228 for three, $438 for six and $828 for twelve on its product pages
  • Flat pricing stated not to rise with dose or across months on the same plan
  • No membership fee and no long-term contract — cancel anytime

What to weigh up

  • The $79 and $129 are labeled sale prices against a $299 regular price, so confirm your renewal is charged the same
  • Dose strengths behind each price are not published, so ask what your maintenance dose costs
  • No individual medical director or prescriber is named — care is attributed to a third-party network (OpenLoop Health) rather than Embody's own clinicians

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Mint MedEmbody
Normalized Cost/Month
Mint Med:
96/100
Embody:
87/100
Price Transparency
Mint Med:
94/100
Embody:
84/100
Nationwide Access
Mint Med:
66/100
Embody:
86/100
Formulation Options
Mint Med:
66/100
Embody:
77/100
Clinical Oversight
Mint Med:
74/100
Embody:
83/100
Contract Flexibility
Mint Med:
73/100
Embody:
25/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.